Hospex

Quick links to important sections

Hospex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hospex

Property Description
Active Ingredient Glutaraldehyde (Glutaral)
Form Aqueous Solution (Liquid)
Pharmacological Class High-Level Disinfectant / Chemical Sterilant
Common Use Cold Sterilization of Medical Equipment
Origin Synthetic Chemical Agent (Dialdehyde)

What is Hospex? Definition and Pharmacological Classification

Hospex is a proprietary liquid preparation whose active chemical agent is Glutaraldehyde, also known by the official designation Glutaral. It is clinically recognized for its essential role in infection control and is categorized as both a High-Level Disinfectant and a Chemical Sterilant. This classification signifies its unique ability to achieve total microbial inactivation. The product’s positioning is aimed specifically at professional healthcare environments requiring rigorous sterility protocols, and its purpose is strictly non-therapeutic for the human body.

Glutaraldehyde Composition and Synthetic Origin

The active core of Hospex is Glutaraldehyde, a potent synthetic chemical agent that belongs to the dialdehyde family. This formulation is supplied as a single-ingredient product in the form of an aqueous solution—a clear, liquid preparation where the glutaraldehyde is dissolved in a purified water vehicle. This specific makeup allows Glutaraldehyde to function as a powerful cross-linking reagent, meaning it chemically alters the structures of microbes to disable them. This aqueous solution format is standard for this class of sterilant, facilitating its use through simple immersion techniques, such as preparing endoscopes for reuse.

General Purpose: Why is a Chemical Sterilant Used in Medical Settings?

The principal function of this agent is to achieve cold sterilization for specialized medical instruments, particularly those that are sensitive to the high temperatures involved in steam sterilization. This general purpose is critical for ensuring patient safety, as the Glutaraldehyde mechanism permanently disables microbial life, including resistant bacterial spores. Glutaraldehyde-based products are included on lists of chemical sterilants cleared for high-level medical disinfection, reflecting the agent's standing and supporting the essential need for sterile equipment in clinical practice.

What side effects are possible with Hospex?

Possible Side Effects and Safety Information

The official safety profile for Hospex (Glutaraldehyde Aqueous Solution), classified as a high-level disinfectant and chemical sterilant, is defined by risks associated with occupational exposure to its liquid or vapor, rather than therapeutic use.

Adverse Reaction Scope

The adverse reactions documented by regulatory and public health authorities are primarily grouped into the following System-Organ Classes:

  • Respiratory, Thoracic and Mediastinal Disorders: Documented effects include irritation of the throat and lungs, cough, dyspnea (shortness of breath), wheezing, and the development of occupational asthma [NIH].
  • Skin and Subcutaneous Tissue Disorders: Reactions include both irritant and allergic contact dermatitis, rash, hives (urticaria), and localized skin irritation [FDA].
  • Eye Disorders: Common effects are burning eyes, conjunctivitis, and excessive tearing (lacrimation) [NIH].

Serious Adverse Reactions and Safety Patterns

Authorities highlight that concentrated solutions can be corrosive, posing a risk of severe, irreversible damage to exposed eyes and skin. The development of occupational asthma and severe allergic contact dermatitis are recognized as serious adverse reactions that can occur with chronic exposure [OSHA].

Adverse effects are directly related to the concentration and duration of exposure. Irritant symptoms are often immediate (acute), while allergic sensitization and conditions like asthma develop over time with repeated exposure.

Population-Specific Considerations: Individuals with pre-existing respiratory conditions (such as asthma or COPD) or a history of skin hypersensitivity are noted to have an increased susceptibility to adverse effects upon exposure.

Safety-Related Restrictions

Regulatory documentation mandates that the use of this agent is contingent upon maintaining adequate ventilation to control airborne vapor concentration below established limits. Prevention of dermal and ocular contact is also a prerequisite, requiring the use of mandated Personal Protective Equipment (PPE) [OSHA]. The safety profile is thus managed through environmental and procedural restrictions, rather than traditional clinical monitoring.

Overdose and Emergency Response

The official regulatory documentation defines the overdose profile for the chemical agent Hospex (Glutaraldehyde) as acute chemical exposure or poisoning. The documented manifestations are centered on its corrosive properties, which include severe chemical burns to the skin and eyes, and severe damage to the respiratory tract leading to coughing, wheezing, and shortness of breath. Systemic toxicity is also noted in regulatory sources, with symptoms such as headache, nausea, and vomiting.

Regulators classify the substance as fatal if inhaled and toxic if swallowed. Severe outcomes from systemic poisoning may involve irreversible organ damage, including Acute Kidney Injury (AKI) and Hepatitis. The official guidance specifies that immediate medical attention must be sought for any eye contact, ingestion, or severe respiratory symptoms following inhalation exposure.

Mandatory emergency actions include immediately removing the person from the exposure source and copiously flushing exposed skin or eyes with water for at least fifteen minutes. If ingestion has occurred, the official instruction is to Do NOT induce vomiting. Individuals with severe exposure are noted to potentially require hospital monitoring for 24 to 48 hours to assess for delayed respiratory complications.

Therapeutic Uses of Hospex

The primary benefit derived from the use of this chemical agent is the comprehensive mitigation of Infection Risk for patients undergoing medical procedures. This critical use is centered on its classification as a tool that plays a role in managing patient risk and helps limit the transmission of infectious illness.

Hospex is relevant across therapeutic domains involving infectious risk control, applied in addressing the potential for Healthcare-Associated Infections (HAIs), cross-contamination, and the presence of resilient pathogens like bacterial spores on reusable equipment. The process is part of the system that helps maintain functional stability during invasive and diagnostic procedures such as endoscopy or bronchoscopy. This supports patients during difficult symptomatic phases by addressing the potential for illness from challenging infectious agents.

Quick Fact: Safety for Semi-Critical Instruments

This agent is commonly used when patient care involves instruments that cannot be subjected to the heat of steam sterilization, contributing to a critical level of pathogen control.

Eligibility and Restrictions for Use

Who Can and Cannot Use Hospex?

Hospex (Glutaraldehyde) is officially classified as a chemical sterilant for medical devices and is not a drug for human administration. Consequently, its official eligibility profile is defined by occupational health and safety regulations, not by traditional patient criteria like age or organ function.

Contraindicated and Restricted Populations

Classification Population Restriction Rationale Context
Contraindicated Any individual with a documented Glutaraldehyde allergy or history of respiratory sensitisation (asthma). High risk of severe allergic reaction or asthma-like symptoms upon exposure.
Contraindicated Use in a manner resulting in direct, unprotected contact with the liquid or high-concentration vapor. The chemical is corrosive and poses a risk of severe skin and eye damage.
Restricted Healthcare workers operating without mandatory Personal Protective Equipment (PPE) or in areas lacking adequate ventilation to control vapor concentration. Use is conditional on maintaining strict governmental workplace exposure limits.

Patient and Age-Group Eligibility Status

Patient-based eligibility rules regarding age (pediatric, older adult), hepatic function, or renal function are not documented in the official labeling. Use is restricted solely to trained professionals in healthcare settings, and is not established for the general public or home use.

What should I know about interactions with other medicines?

Hospex Interactions with other medicines and products

Interaction classifications for Glutaraldehyde solutions differ from those of systemic medicines, focusing instead on chemical compatibility and stability documented in official regulatory guidance. The profile establishes mandatory constraints on co-administration with other chemical agents and substances that can chemically alter the solution's effectiveness.


Chemical Incompatibility Restrictions

The most critical interaction patterns are related to chemical incompatibility, which are formally documented as restrictions to prevent hazardous reactions and maintain a safe working environment. The co-administration, or mixing, of Glutaraldehyde with specific chemical groups is strictly prohibited:

  • Strong Oxidizing Agents and Alkaline Substances: Combining the solution with strong oxidizers or highly alkaline compounds is contraindicated due to chemical instability and the potential for a hazardous chemical reaction.
  • Chlorine Compounds: Mixing Glutaraldehyde with other active disinfectants, particularly those containing chlorine (such as bleach), is prohibited to prevent the generation of toxic, volatile fumes.

Substance Interaction Affecting Stability

Substances that interact with the active chemical agent can cause a degradation interaction, which functionally reduces the active concentration and shortens the solution’s approved effective lifespan:

  • Organic Matter Residue: Exposure to excessive organic material, such as proteinaceous residue on equipment, interacts with the solution, leading to a reduction in the available active ingredient.
  • Water Quality: The stability of the solution is sensitive to water composition. High mineral content (hard water) can chemically alter the solution, reducing its stability and shortening the time interval for which the product is considered effective.

Mechanism of Action

Irreversible Chemical Destruction of Microbial Targets

The Hospex (Glutaraldehyde) mechanism is defined by the direct, non-selective chemical destruction of microbial components. It acts as a dialdehyde agent, forming covalent chemical cross-links with essential nucleophilic groups (specifically amino groups on proteins) found on the structural and metabolic proteins of microorganisms. This irreversible chemical modification causes immediate denaturation and functional loss of critical enzymes, while simultaneously damaging the microbial DNA and compromising the integrity of the cell wall and membrane.


Broad Cellular Inactivation and Sterilization

This molecular damage initiates a mechanistic cascade resulting in the cessation of essential microbial life processes. By disabling proteins necessary for metabolism and the genetic material required for replication, the mechanism achieves broad cellular inactivation, extending to resilient forms like bacterial spores. The resulting physiological consequence is the biocidal effect that defines its function as a chemical sterilant. The mechanistic action is constrained by environmental factors like temperature and the presence of organic debris, which can chemically compete for the active agent.

Dosage and Administration Information

Official Application Protocol for Hospex (Glutaraldehyde)

The usage of Hospex is governed by strict, non-therapeutic protocols for the chemical reprocessing of reusable medical devices, established according to clinical standards. The guidelines below define the official, standardized application process for this high-level disinfectant and sterilant.


Administration Scope (Chemical Sterilant Protocol)

Category Official Instruction
Route of Administration Application via Immersion of fully cleaned medical devices into the solution, or use within an Automated Endoscope Reprocessor (AER) system.
Dosing Schedule The solution must maintain a Minimum Effective Concentration (MEC), typically 1.8% to 2.1% Glutaraldehyde, which must be verified daily before use.
Preparation Requirements Efficacy is dependent on the mandatory pre-cleaning of the device to remove all organic soil prior to immersion. Many formulations also require a single activation step before the first use.
Special Procedural Conditions The application must occur at the specified working temperature, often ambient (20 C to 25 C).

Resulting Procedural Structure

Official Step Sequence:

  • Monitor: The solution is tested daily to verify the concentration is above the official MEC.
  • Immerse: The cleaned device is submerged for the exact required contact time (e.g., 20 minutes for high-level disinfection or 10 hours for sterilization).
  • Rinse: The device is thoroughly rinsed with sterile water to remove all chemical residue before the instrument is deemed ready for clinical use.

The instructions dictate a maximum reuse life for the solution, typically 14 days or 28 days, after which the chemical must be replaced regardless of MEC test results. This structure ensures the necessary concentration and exposure duration are strictly maintained throughout the entire reprocessing cycle.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hospex

Evidence for Use as a Chemical Sterilant for Devices

The research behind Glutaraldehyde, the active agent in Hospex, differs significantly from studies conducted on medicines taken by people. This product is not used to treat human disease but was studied for its role in infection control on medical equipment. The body of evidence consists mainly of standardized laboratory validation studies (in-vitro) that research examined for the purpose of regulatory assessment as a sterilant or high-level disinfectant. These studies are conducted under controlled conditions to determine the agent's ability to kill specific microorganisms.

Research examined the chemical agent's performance in achieving a microbial kill on inanimate surfaces, such as those found on endoscopes and other surgical tools. The main focus of these studies was to evaluate the elimination of highly resistant organisms, including bacterial spores (which was studied for its potential to be difficult to eliminate) and mycobacteria. Findings describe patterns observed in the studies that the agent met the defined thresholds for microbial kill as established for this research context when used exactly as specified. These results reflect the specific conditions under which they were conducted.

Research on Microbial Kill Consistency and Regulatory Standards

Studies monitored the minimum effective concentrations (MEC) and the necessary contact time to ensure the required microbial kill is achieved. This type of research contributes to the broader evidence landscape by helping regulators evaluate the evidence used for product authorization in contexts related to Healthcare-Associated Infections (HAIs).

The standardized laboratory tests generally reported consistent patterns of complete microbial inactivation when the recommended conditions were strictly adhered to. This consistency is a factor in how governmental bodies evaluate the evidence for the product's authorization in contexts related to HAIs. The data show patterns related to the importance of following the exact protocol to ensure the agent performs as was evaluated in achieving high-level disinfection or sterilization.


What is Still Uncertain About Hospex Research

While the laboratory data supporting the agent's microbial efficacy are extensive, certain aspects remain uncertain because the evidence is not based on human clinical trials. The primary limitation is the reliance on in-vitro tests, meaning the research does not fully account for all variables encountered in a real healthcare setting.

For instance, Research describes that the performance of the process is strongly associated with the thorough mechanical pre-cleaning of medical devices by healthcare personnel before they are immersed in the solution. Evidence is limited regarding the precise impact of imperfect pre-cleaning on the final sterilization outcome. Additionally, patterns were observed where failure was attributed to pre-cleaning steps, rather than the chemical agent itself. Research does not determine whether an individual piece of equipment will be sterile under variable protocol conditions.

Key Studies & References

  1. AOAC Method 966.04: Sporicidal Activity of Disinfectants Test - Method II methodology (EPA)

Frequently Asked Questions (FAQ)

Common questions about Hospex (FAQ)

Q: What does the MEC of 1.8% to 2.1% Glutaraldehyde refer to?

MEC stands for Minimum Effective Concentration. According to regulatory documents, this is the lowest authorized concentration of glutaraldehyde at which the solution is proven to maintain its intended function. If testing shows the solution is below this concentration, the product documentation indicates it may not reliably perform as a high-level disinfectant or sterilant.

Q: How long must a device stay submerged to achieve sterilization, not just high-level disinfection?

Official product information suggests that the contact time necessary for sterilization is separate from the time required for high-level disinfection. For many glutaraldehyde products cleared by regulatory bodies, the specified immersion time to achieve sterilization is 10 hours, provided the solution is at the designated temperature and concentration.

Q: What PPE is required for safely handling and using Hospex?

Official safety guidelines, such as those from OSHA and the CDC, require the use of specific Personal Protective Equipment ( PPE) to limit occupational exposure. This typically includes, but is not limited to, using eye protection, protective clothing, and chemical-resistant gloves, as specified in the product's official safety data. This is necessary to prevent skin and eye contact.

Q: Where do I properly dispose of the used chemical solution after its use life is over?

Regulatory guidance and mandated safety data sheets require that spent glutaraldehyde solutions are handled as hazardous chemical waste. Disposal must adhere strictly to local, state, and federal environmental regulations. The solution should not be disposed of in a standard drain unless it is handled according to specific local sewer ordinances and approved neutralization or dilution protocols.

Q: Are there any instructions for storage of the unused chemical solution?

Official product information, derived from safety data sheets, provides clear instructions for storage. Unused glutaraldehyde solutions should be stored in their original, tightly closed containers in an environment that is cool, dry, and well-ventilated. The solution must also be kept away from specific incompatible materials, such as acids, strong oxidizing agents, and bases.

Q: What should I do if the solution spills or splashes on the floor?

Official safety data sheets outline a specific spill protocol, which includes immediately limiting access to the area and containing the solution using specialized chemical absorbent materials while appropriate PPE is worn. The resulting chemical waste must be managed according to mandated disposal guidelines.

How should Hospex be stored and disposed of?

How to Store and Dispose of Hospex

Hospex (Glutaraldehyde Solution) must be stored strictly according to the conditions defined in the official regulatory labeling. The product is required to be stored at controlled room temperature, generally between 20 C and 25 C.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature; Do not freeze.
Protection Protect from light and keep the container tightly closed.
Safety Keep the solution out of the sight and reach of children.
Stability Activated solutions have a limited use-life and must be discarded thereafter.

Disposal Instructions

Disposal of unused, expired, or spent Hospex solution and containers must adhere to local and national regulations for chemical waste. It is mandatory not to dispose of the product into domestic wastewater systems or household trash, as the solution is often classified as regulated chemical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hospex found in:

A-Z Index: